Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: New Dutton report
Reply New Message
Prev Message Back To Forum Threaded View Next Message
I don't take the dutton reports too seriously.  Their price target is $0.75 in 12 months. Obviously they are not aware that invalidating patents is next to  impossible. With that known, PTSC's patents must stand. We might see $0.75 by the end of this week.
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply